Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Q3 2025 value amounting to 0.22%.

  • Catalyst Pharmaceuticals' Return on Invested Capital rose 300.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.26% for FY2024, which is 1100.0% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Return on Invested Capital stood at 0.22% for Q3 2025, which was up 300.0% from 0.23% recorded in Q2 2025.
  • Catalyst Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.41% during Q1 2021, with a 5-year trough of 0.09% in Q2 2024.
  • For the 5-year period, Catalyst Pharmaceuticals' Return on Invested Capital averaged around 0.23%, with its median value being 0.22% (2025).
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Return on Invested Capital plummeted by -3100bps in 2021 and then surged by 1400bps in 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.19% in 2021, then surged by 46bps to 0.28% in 2022, then tumbled by -48bps to 0.15% in 2023, then soared by 43bps to 0.21% in 2024, then increased by 4bps to 0.22% in 2025.
  • Its Return on Invested Capital was 0.22% in Q3 2025, compared to 0.23% in Q2 2025 and 0.23% in Q1 2025.